TPB Turning Point Brands, Inc.
Tobacco Products · NYSE · SEC CIK 1290677 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY23.8%
TTM net income YoY-47.7%
TTM EPS YoY-52.4%
Revenue 3-yr CAGR16.0%
Net income 3-yr CAGR31.6%
Margins
Gross margin58.4%
Operating margin10.9%
Net margin5.1%
FCF margin4.4%
EBITDA margin—
Returns
ROE7.1%
ROA3.4%
ROIC (approx.)11.8%
Asset turnover0.68x
Leverage & solvency
Liabilities / assets46.9%
Debt / equity0.70x
Current ratio5.83x
Interest coverage2.29x
Cash quality & payout
Operating cash flow / net income1.25x
Accruals ratio-0.9%
Payout ratio22.8%
Capex / revenue1.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $463.06M | $360.66M |
| Cost of revenue | $198.75M | $159.09M |
| Gross profit | $264.31M | $201.56M |
| R&D expense | $900,000 | $1.30M |
| SG&A expense | $168.99M | $122.41M |
| Operating income | $95.33M | $80.83M |
| Interest expense | $25.39M | $18.53M |
| Pretax income | $83.14M | $64.96M |
| Income tax | $14.99M | $16.93M |
| Net income | $58.16M | $39.81M |
| EPS (basic) | 3.18 | 2.24 |
| EPS (diluted) | 3.11 | 2.14 |
| Dividends declared per share | 0.30 | 0.28 |
| Weighted avg. shares (diluted) | 18.73M | 19.36M |
| Balance sheet | ||
| Cash & equivalents | $222.76M | $48.94M |
| Receivables | $25.73M | $9.62M |
| Inventory | $107.99M | $96.25M |
| Current assets | $417.15M | $198.21M |
| PP&E, net | $36.25M | $26.34M |
| Goodwill | $136.10M | $135.93M |
| Intangibles | $64.04M | $65.25M |
| Total assets | $763.75M | $493.35M |
| Current liabilities | $75.01M | $44.82M |
| Short-term debt | — | $0 |
| Long-term debt | $293.62M | $248.60M |
| Total debt | $293.62M | $248.60M |
| Total liabilities | $391.77M | $302.97M |
| Shareholders' equity | $354.30M | $187.98M |
| Net debt | $70.86M | $199.66M |
| Cash flow statement | ||
| Operating cash flow | $57.37M | $67.06M |
| Capital expenditure | $13.53M | $4.62M |
| Free cash flow | $43.84M | $62.44M |
| Investing cash flow | -$31.67M | -$10.51M |
| Financing cash flow | $148.27M | -$128.28M |
| Stock-based compensation | $6.97M | $7.24M |
| Dividends paid | $5.52M | $4.91M |
| Share buybacks | $0 | $5.05M |
Free plan shows the latest 2 periods; Pro shows all 12 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.